Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Vaccines

  Free Subscription


13.03.2017

1 BMJ
1 J Infect
2 J Virol
1 Lancet Infect Dis
1 Lancet Respir Med
2 MMWR Morb Mortal Wkly Rep
1 Pediatrics
6 PLoS One
14 Vaccine


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    BMJ


  1. Association of BCG, DTP, and measles containing vaccines with childhood mortality: systematic review.
    BMJ. 2017;356:j1241.
    PubMed     Text format    


    J Infect

  2. MAZZOLA G, Macaluso FS, Adamoli L, Renna S, et al
    Diagnostic and vaccine strategies to prevent infections in patients with inflammatory bowel disease.
    J Infect. 2017 Mar 2. pii: S0163-4453(17)30075.
    PubMed     Text format     Abstract available


    J Virol

  3. BOYOGLU-BARNUM S, Todd SO, Meng J, Barnum TR, et al
    Mutating the CX3C motif in the G protein should make a live respiratory syncytial virus vaccine safer and more effective.
    J Virol. 2017 Mar 8. pii: JVI.02059-16. doi: 10.1128/JVI.02059.
    PubMed     Text format     Abstract available

  4. MENG X, Rose L, Han Y, Deng J, et al
    Vaccinia virus A6 is a two-domain protein requiring a cognate N-terminal domain for full viral membrane assembly activity.
    J Virol. 2017 Mar 8. pii: JVI.02405-16. doi: 10.1128/JVI.02405.
    PubMed     Text format     Abstract available


    Lancet Infect Dis

  5. IRO MA, Sadarangani M, Goldacre R, Nickless A, et al
    30-year trends in admission rates for encephalitis in children in England and effect of improved diagnostics and measles-mumps-rubella vaccination: a population-based observational study.
    Lancet Infect Dis. 2017 Mar 1. pii: S1473-3099(17)30114.
    PubMed     Text format     Abstract available


    Lancet Respir Med

  6. ESPOSITO S, Principi N
    Clinical trial research in focus: factors that hamper the development and evaluation of influenza vaccines.
    Lancet Respir Med. 2017;5:164-166.
    PubMed     Text format    


    MMWR Morb Mortal Wkly Rep


  7. Announcement: Release of National Association of State Public Health Veterinarians' 2016 Compendium of Animal Rabies Prevention and Control.
    MMWR Morb Mortal Wkly Rep. 2017;66:148.
    PubMed     Text format     Abstract available

  8. KIM DK, Riley LE, Harriman KH, Hunter P, et al
    Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older - United States, 2017.
    MMWR Morb Mortal Wkly Rep. 2017;66:136-138.
    PubMed     Text format     Abstract available


    Pediatrics

  9. PEAD PJ
    Vaccination's Forgotten Origins.
    Pediatrics. 2017 Mar 7. pii: e20162833. doi: 10.1542/peds.2016-2833.
    PubMed     Text format    


    PLoS One

  10. HEQUET D, Rouzier R
    Determinants of geographic inequalities in HPV vaccination in the most populated region of France.
    PLoS One. 2017;12:e0172906.
    PubMed     Text format     Abstract available

  11. TEFERI WM, Desaulniers MA, Noyce RS, Shenouda M, et al
    The vaccinia virus K7 protein promotes histone methylation associated with heterochromatin formation.
    PLoS One. 2017;12:e0173056.
    PubMed     Text format     Abstract available

  12. DAYER JA, Siegrist CA, Huttner A
    Volunteer feedback and perceptions after participation in a phase I, first-in-human Ebola vaccine trial: An anonymous survey.
    PLoS One. 2017;12:e0173148.
    PubMed     Text format     Abstract available

  13. ISLAM MA, Grosse-Brinkhaus C, Proll MJ, Uddin MJ, et al
    PBMC transcriptome profiles identifies potential candidate genes and functional networks controlling the innate and the adaptive immune response to PRRSV vaccine in Pietrain pig.
    PLoS One. 2017;12:e0171828.
    PubMed     Text format     Abstract available

  14. CHAPMAN R, Jongwe TI, Douglass N, Chege G, et al
    Heterologous prime-boost vaccination with DNA and MVA vaccines, expressing HIV-1 subtype C mosaic Gag virus-like particles, is highly immunogenic in mice.
    PLoS One. 2017;12:e0173352.
    PubMed     Text format     Abstract available

  15. KIM JI, Lee I, Park S, Bae JY, et al
    Phylogenetic relationships of the HA and NA genes between vaccine and seasonal influenza A(H3N2) strains in Korea.
    PLoS One. 2017;12:e0172059.
    PubMed     Text format     Abstract available


    Vaccine

  16. BEYERLEIN A, Strobl AN, Winkler C, Carpus M, et al
    Vaccinations in early life are not associated with development of islet autoimmunity in type 1 diabetes high-risk children: Results from prospective cohort data.
    Vaccine. 2017 Mar 3. pii: S0264-410X(17)30262.
    PubMed     Text format     Abstract available

  17. GERSHWIN LJ, Behrens NE, McEligot HA, Carvallo-Chaigneau FR, et al
    A recombinant subunit vaccine for bovine RSV and Histophilus somni protects calves against dual pathogen challenge.
    Vaccine. 2017 Mar 5. pii: S0264-410X(17)30125.
    PubMed     Text format     Abstract available

  18. SETH L, Bingham Ferlez KM, Kaba SA, Musser DM, et al
    Development of a self-assembling protein nanoparticle vaccine targeting Plasmodium falciparum Circumsporozoite Protein delivered in three Army Liposome Formulation adjuvants.
    Vaccine. 2017 Mar 5. pii: S0264-410X(17)30243.
    PubMed     Text format     Abstract available

  19. OVSYANNIKOVA IG, Larrabee BR, Schaid DJ, Poland GA, et al
    Immunoglobulin GM and KM genes and measles vaccine-induced humoral immunity.
    Vaccine. 2017 Mar 6. pii: S0264-410X(17)30249.
    PubMed     Text format     Abstract available

  20. LIU CC, Wu SC, Wu SR, Lin HY, et al
    Enhancing enterovirus A71 vaccine production yield by microcarrier profusion bioreactor culture.
    Vaccine. 2017 Mar 6. pii: S0264-410X(17)30245.
    PubMed     Text format     Abstract available

  21. PORTER CK, Sorrell T, Mitra I, Riddle MS, et al
    Vaccination of active component US military personnel against Salmonella Typhi.
    Vaccine. 2017 Mar 3. pii: S0264-410X(17)30263.
    PubMed     Text format     Abstract available

  22. SEIB K, Pollard AJ, de Wals P, Andrews RM, et al
    Policy making for vaccine use as a driver of vaccine innovation and development in the developed world.
    Vaccine. 2017;35:1380-1389.
    PubMed     Text format     Abstract available

  23. JACKSON LA, Frey SE, El Sahly HM, Mulligan MJ, et al
    Safety and immunogenicity of a modified vaccinia Ankara vaccine using three immunization schedules and two modes of delivery: A randomized clinical non-inferiority trial.
    Vaccine. 2017 Feb 27. pii: S0264-410X(17)30226.
    PubMed     Text format     Abstract available

  24. WYSOCKI J, Center KJ, Brzostek J, Majda-Stanislawska E, et al
    A randomized study of fever prophylaxis and the immunogenicity of routine pediatric vaccinations.
    Vaccine. 2017 Mar 2. pii: S0264-410X(17)30229.
    PubMed     Text format     Abstract available

  25. MYERS TR, McNeil MM, Ng CS, Li R, et al
    Adverse events following quadrivalent meningococcal CRM-conjugate vaccine (Menveo(R)) reported to the Vaccine Adverse Event Reporting system (VAERS), 2010-2015.
    Vaccine. 2017 Mar 2. pii: S0264-410X(17)30224.
    PubMed     Text format     Abstract available

  26. GIERSING BK, Vekemans J, Nava S, Kaslow DC, et al
    Report from the World Health Organization's third Product Development for Vaccines Advisory Committee (PDVAC) meeting, Geneva, 8-10th June 2016.
    Vaccine. 2017 Mar 2. pii: S0264-410X(16)31205.
    PubMed     Text format     Abstract available

  27. HOTEZ PJ
    Developing and financing neglected disease vaccines in our new era of "blue marble health" and the anthropocene epoch.
    Vaccine. 2017 Mar 2. pii: S0264-410X(17)30165.
    PubMed     Text format     Abstract available

  28. KUCK LR, Saye S, Loob S, Roth-Eichhorn S, et al
    VaxArray assessment of influenza split vaccine potency and stability.
    Vaccine. 2017 Mar 2. pii: S0264-410X(17)30222.
    PubMed     Text format     Abstract available

  29. PARRINO J, McNeil SA, Lawrence SJ, Kimby E, et al
    Safety and immunogenicity of inactivated varicella-zoster virus vaccine in adults with hematologic malignancies receiving treatment with anti-CD20 monoclonal antibodies.
    Vaccine. 2017 Mar 3. pii: S0264-410X(16)30990.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Vaccines is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: